Stock Screener App

Gratuito -

Installare

2.23

5.69% 0.12

Maravai Lifesciences Holdings Inc (MRVI)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché MRVI Giù? Forum Previsione

Maravai Lifesciences Holdings Inc Borsa (MRVI) Ultime notizie

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

SG Americas Securities LLC Acquires 662,861 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World

Maravai LifeSciences appoints Bernd Brust as CEO - MSN

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Reach Out - ACCESS Newswire

Investors Purchase Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - Defense World

MRVI Set to Host Global Bioproduction Conference Call | MRVI Stock News - GuruFocus

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out - ACCESS Newswire

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of “Hold” by Analysts - Defense World

Maravai LifeSciences names Bernd Brust as new CEO By Investing.com - Investing.com South Africa

Maravai Lifesciences Appoints Bernd Brust As CEO & Member Of Its Board Of Directors - MarketScreener

Maravai LifeSciences Names Bernd Brust as CEO - marketscreener.com

Maravai LifeSciences (MRVI) Names Bernd Brust as New CEO | MRVI Stock News - GuruFocus

Maravai Lifesciences Appoints Bernd Brust as New CEO - TipRanks

Maravai LifeSciences Appoints Bernd Brust as Chief Executive Off - GuruFocus

Maravai LifeSciences names Bernd Brust as new CEO - Investing.com Australia

Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors | MRVI Stock News - GuruFocus

Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors - GlobeNewswire

Life Sciences Leader Maravai Taps Industry Veteran Bernd Brust as CEO to Accelerate Growth in Genomic Medicine - Stock Titan

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Sold by Two Sigma Investments LP - Defense World

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $1.37 Million Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect - ACCESS Newswire

Maravai LifeSciences (NASDAQ:MRVI) Stock Price Up 8.5% – Time to Buy? - Defense World

Jane Street Group LLC Cuts Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out - ACCESS Newswire

Quantoom Biosciences and TriLink BioTechnologies Sign a Supply and License Agreement - Insider Monkey

TriLink and Quantoom partner to expand global vaccine access By Investing.com - Investing.com South Africa

MRVI: TriLink BioTechnologies Partners with Quantoom for Enhanced mRNA Production | MRVI Stock News - GuruFocus

TriLink and Quantoom partner to expand global vaccine access - Investing.com Australia

Maravai's TriLink, Quantoom Sign License, Supply Agreement - marketscreener.com

Leading COVID-19 Vaccine Technology CleanCap Expands Global Access Through Quantoom Partnership - Stock Titan

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stock Holdings Cut by Bank of America Corp DE - Defense World

ProShare Advisors LLC Raises Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World

Maravai LifeSciences Announces Shareholder Meeting Results - Investing.com Australia

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI) - Defense World

Maravai Lifesciences Holds Annual Shareholders Meeting - TipRanks

Maravai LifeSciences Announces Shareholder Meeting Results By Investing.com - Investing.com Canada

BNP Paribas Financial Markets Purchases Shares of 66,443 Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

CORRECTION -- Maravai LifeSciences Releases 2024 Sustainability Report | MRVI Stock News - GuruFocus

Maravai LifeSciences Releases 2024 Sustainability Report Highlighting Product Innovation, Governance Enhancements, and Commitment to Sustainable Growth - Nasdaq

CORRECTIONMaravai LifeSciences Releases 2024 Sustainability Report - The Manila Times

CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report - GlobeNewswire

Maravai Sustainability Report: 10x Manufacturing Expansion Plus Major Green Energy Milestones - Stock Titan

Maravai LifeSciences Releases 2024 Sustainability Report - GlobeNewswire

Maravai LifeSciencesReleases 2024 Sustainability Report - The Manila Times

Maravai LifeSciences Sustainability Report: 49 New Products and 10X GMP Manufacturing Expansion Drive Growth - Stock Titan

Northern Trust Corp Buys 53,474 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World

Revolutionary mRNA Synthesis Kit Achieves 2X Yield, 85% Lower dsRNA: TriLink's Game-Changing Launch - Stock Titan

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Consensus Recommendation of “Hold” by Brokerages - Defense World

Maravai LifeSciences Q1 2025 Earnings Call: Growth Amid Challenges - TipRanks

Price T Rowe Associates Inc. MD Acquires 7,946 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World

GMAB

$20.74

0.29%

RPRX

$36.14

2.09%

SMMT

$20.92

2.60%

INSM

$105.90

0.46%

BNTX

$105.09

2.02%

ONC

$266.80

3.61%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters